Compare BWEN & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BWEN | RFL |
|---|---|---|
| Founded | N/A | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Real Estate |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.1M | 54.4M |
| IPO Year | N/A | N/A |
| Metric | BWEN | RFL |
|---|---|---|
| Price | $3.26 | $1.46 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 322.2K | 143.0K |
| Earning Date | 11-13-2025 | 12-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 63.89 | N/A |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $153,877,000.00 | $1,029,000.00 |
| Revenue This Year | $11.68 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $14.20 | ★ N/A |
| Revenue Growth | N/A | ★ 47.63 |
| 52 Week Low | $1.41 | $1.17 |
| 52 Week High | $3.59 | $3.19 |
| Indicator | BWEN | RFL |
|---|---|---|
| Relative Strength Index (RSI) | 60.04 | 64.11 |
| Support Level | $2.92 | $1.21 |
| Resistance Level | $3.59 | $1.60 |
| Average True Range (ATR) | 0.26 | 0.08 |
| MACD | 0.03 | 0.04 |
| Stochastic Oscillator | 71.10 | 67.44 |
Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.
Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.